Dr. Chelsea Curry, D.O
NPI: 1831452010
Total Payments
$201.16
2024 Payments
$14.66
Companies
7
Transactions
13
Medicare Patients
3,494
Medicare Billing
$163,848
Payment Breakdown by Category
Food & Beverage$201.16 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $201.16 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $62.32 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $38.42 | 3 | $0 (2017) |
| Lexicon Pharmaceuticals, Inc. | $23.73 | 1 | $0 (2017) |
| Roche Diagnostics Corporation | $23.21 | 1 | $0 (2017) |
| Eisai Inc. | $21.98 | 1 | $0 (2017) |
| Abbott Laboratories | $16.84 | 1 | $0 (2017) |
| Siemens Medical Solutions USA, Inc. | $14.66 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.66 | 1 | Siemens Medical Solutions USA, Inc. ($14.66) |
| 2018 | $14.18 | 1 | E.R. Squibb & Sons, L.L.C. ($14.18) |
| 2017 | $172.32 | 11 | E.R. Squibb & Sons, L.L.C. ($48.14) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | Siemens Medical Solutions USA, Inc. | Atellica IM 1300 Analyzer (Device) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: DX - Diagnostics incl. all products and services | ||||||
| 04/17/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: Oncology | ||||||
| 11/08/2017 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: HEMATOLOGY | ||||||
| 06/16/2017 | Abbott Laboratories | Architect system (Device), Architect system, Architect system | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diagnostics | ||||||
| 05/16/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $10.90 | General |
| Category: Oncology | ||||||
| 05/03/2017 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: HEMATOLOGY | ||||||
| 04/27/2017 | Roche Diagnostics Corporation | TD BenchMark Platforms (Device) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Tissue Diagnostics | ||||||
| 04/19/2017 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.45 | General |
| Category: Oncology | ||||||
| 02/22/2017 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: HEMATOLOGY | ||||||
| 02/14/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.48 | General |
| Category: Oncology | ||||||
| 01/26/2017 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| Category: Oncology | ||||||
| 01/10/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.31 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 727 | 1,207 | $311,872 | $33,552 |
| 2022 | 12 | 868 | 1,397 | $362,533 | $41,492 |
| 2021 | 13 | 907 | 1,463 | $350,589 | $41,368 |
| 2020 | 11 | 992 | 1,603 | $396,774 | $47,437 |
Total Patients
3,494
Total Services
5,670
Medicare Billing
$163,848
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 292 | 448 | $116,480 | $12,618 | 10.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 86 | 135 | $63,180 | $8,485 | 13.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 55 | 238 | $61,880 | $5,162 | 8.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 90 | 110 | $28,600 | $2,940 | 10.3% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 11 | 13 | $7,904 | $1,443 | 18.3% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 96 | 98 | $8,624 | $932.96 | 10.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 20 | 43 | $6,708 | $876.77 | 13.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 61 | 66 | $12,672 | $575.26 | 4.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 16 | 56 | $5,824 | $518.52 | 8.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 333 | 529 | $137,540 | $15,597 | 11.3% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 91 | 176 | $82,368 | $11,397 | 13.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 65 | 236 | $61,360 | $5,232 | 8.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 111 | 118 | $30,680 | $3,229 | 10.5% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 12 | 13 | $7,904 | $1,490 | 18.8% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2022 | 109 | 116 | $10,208 | $1,138 | 11.1% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 13 | 16 | $5,328 | $781.52 | 14.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2022 | 12 | 32 | $4,992 | $665.22 | 13.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 26 | 30 | $2,490 | $656.57 | 26.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2022 | 63 | 66 | $12,672 | $587.99 | 4.6% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 22 | 54 | $5,616 | $505.97 | 9.0% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2022 | 11 | 11 | $1,375 | $211.04 | 15.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 323 | 513 | $133,380 | $15,340 | 11.5% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2021 | 75 | 127 | $60,372 | $8,465 | 14.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 58 | 209 | $54,340 | $4,779 | 8.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 87 | 103 | $26,780 | $2,903 | 10.8% |
About Dr. Chelsea Curry, D.O
Dr. Chelsea Curry, D.O is a Anatomic Pathology & Clinical Pathology healthcare provider based in Independence, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1831452010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chelsea Curry, D.O has received a total of $201.16 in payments from pharmaceutical and medical device companies, with $14.66 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($201.16).
As a Medicare-enrolled provider, Curry has provided services to 3,494 Medicare beneficiaries, totaling 5,670 services with total Medicare billing of $163,848. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Independence, MO
- Active Since 06/21/2012
- Last Updated 05/29/2018
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831452010
Products in Payments
- OPDIVO (Biological) $62.32
- JADENU (Drug) $38.42
- Xermelo (Drug) $23.73
- TD BenchMark Platforms (Device) $23.21
- Lenvima (Drug) $21.98
- Architect system (Device) $16.84
- Atellica IM 1300 Analyzer (Device) $14.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.